Bausch + Lomb Corporation was spun out of Bausch Health Companies Inc. this year - after years of speculation - and the new entity is an eye disease specialist. The parent company owns nearly 90% of ...
An update from Bausch + Lomb Corporation ( ($BLCO) ) is now available. Bausch + Lomb Corporation announced that its senior leadership team, ...
Bausch + Lomb was delighted to welcome employees and their families to the first-ever Santa Experience at the Tower Hotel to ...
A money manager at Carl Icahn’s investment firm is suing Bausch + Lomb Corp. and his billionaire employer, alleging he was ...
Listen and subscribe to Opening Bid on Apple Podcasts, Spotify, YouTube, or wherever you find your favorite podcasts. After completing $300 billion in healthcare deals over several decades, there is ...
New Lens is the Most Advanced Soft Contact Lens Design in Bausch + Lomb History Only Multifocal Toric Lens that Offers Eye Care Professionals a Convenient Same-Day Fit to Address Patients with ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced three podium ...
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live ...
Bausch & Lomb reported 5.1% year-over-year revenue growth and $0.07 adjusted diluted earnings per share for the second quarter, both ahead of FactSet consensus estimates. Why it matters: Despite ...
Bausch + Lomb recently allocated a US$2.80 billions tranche of new term B loans to refinance existing facilities, lowering interest margins and extending some maturities to January 15, 2031. Analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results